Safety evaluation of the food enzyme rennet paste from the abomasum of suckling goats, lambs and calves [PDF]
, 2021 [EN] The food enzyme rennet paste containing chymosin (EC 3.4.23.4), pepsin A (EC 3.4.23.1) and triacylglycerol lipase (triacylglycerol acylhydrolase, EC 3.1.1.3) is prepared from the abomasum of suckling goats, lambs and calves by Caglificio Clerici S.p.
Barat Baviera, José Manuel +14 more
core +1 more source
Fate of Neuraminidases of Influenza A Viruses [PDF]
E3S Web of Conferences, 2020 The current COVID-19 pandemic creates the biggest health and economic challenges to the world. However, not much knowledge is available about this coronavirus, SARS-CoV-2, because of its novelty.
Yan Shaomin, Wu Guang
doaj +1 more source
Digestive System Dynamics in Molecular Communication Perspectives [PDF]
arXiv, 2021 Consumption of food in excess of the required optimal nutritional requirements has already resulted in a global crisis and this is from the perspective of human health, such as obesity, as well as food waste and sustainability. In order to minimize the impact of these issues, there is a need to develop novel innovative and effective solutions that can ...
arxiv
Safety evaluation of the food enzyme alpha-amylase from a genetically modified bacillus licheniformis (strain NZYM-AN) [PDF]
, 2018 The food enzyme is an α-amylase (4-α-d-glucan glucanohydrolase; EC 3.2.1.1) produced with a genetically modified Bacillus licheniformis strain NZYM-AN by Novozymes A/S. The genetic modifications do not give rise to safety concerns.
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) +1 more
core +2 more sources
Safety evaluation of the food enzyme rennet containing chymosin and pepsin A from the abomasum of suckling goats, lambs and calves [PDF]
, 2022 [EN] The food enzyme containing chymosin (EC 3.4.23.4) and pepsin A (EC 3.4.23.1) is prepared from the abomasum of suckling goats, lambs and calves by Laboratoires Abia. The food enzyme is intended to be used in milk processing for cheese production.
Barat Baviera, José Manuel +14 more
core +1 more source
The clinical spectrum of SMA‐PME and in vitro normalization of its cellular ceramide profile
Annals of Clinical and Translational Neurology, Volume 9, Issue 12, Page 1941-1952, December 2022., 2022 Abstract Objective The objectives of this study were to define the clinical and biochemical spectrum of spinal muscular atrophy with progressive myoclonic epilepsy (SMA‐PME) and to determine if aberrant cellular ceramide accumulation could be normalized by enzyme replacement.
Michelle M. Lee +16 more
wiley +1 more source
The development of food protein-inorganic hybrid nanoflowers with outstanding role in stabilizing natural pigments [PDF]
arXiv, 2022 Protein-inorganic hybrid nanoflowers (HNFs) possess unique properties in promoting surface reaction and have attracted wide-spread attention as a newly developed nanomaterial. However, the availability of protein sources has up to now been mostly limited to enzymes, which narrows the application of HNFs especially in food industry.
arxiv
Enzymes and food flavor‐A review
Food Biotechnology, 1994 Abstract The use of enzymes in flavor generation in food technology is reviewed. In the first part, important products derived from natural macromolecules present in foods such as fats, proteins, nucleic acids and flavor precursors are discussed in terms of the enzymes involved in the reactions and the relation of the products with flavor. Enzymes that
Christen, Pierre, Lopez-Munguia, A.
openaire +3 more sources
Safety evaluation of the food enzyme rennet containing chymosin and pepsin A from calf abomasum [PDF]
, 2022 [EN] The food enzyme containing chymosin (EC 3.4.23.4) and pepsin A (EC 3.4.23.1) is prepared from the abomasum of calves by RENCO New Zealand. The food enzyme is intended to be used in milk processing for cheese production. As no concerns arise from the
Barat Baviera, José Manuel +14 more
core +1 more source
A transient inflammatory response contributes to oxaliplatin neurotoxicity in mice
Annals of Clinical and Translational Neurology, Volume 9, Issue 12, Page 1985-1998, December 2022., 2022 Abstract Objectives Peripheral neuropathy is a relevant dose‐limiting adverse event that can affect up to 90% of oncologic patients with colorectal cancer receiving oxaliplatin treatment. The severity of neurotoxicity often leads to dose reduction or even premature cessation of chemotherapy.
Aina Calls +9 more
wiley +1 more source